Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutationsNiki Karachaliou, Carlota Costa, Ana Gimenez-Capitan, et al.Pharmaceutics|October 27, 2022
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung CancerCarlos Pedraz-Valdunciel, Stavros Giannoukakos, Ana Giménez-Capitán, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cellsMiguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2014
Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancerMiguel A Molina-Vila, Jordi Bertran-Alamillo, Amaya Gascó, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trialCarlota Costa, Miguel Angel Molina, Ana Drozdowskyj, et al.Lung Cancer (Amsterdam, Netherlands)|August 14, 2010
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patientsFernanda Salazar, Miguel Angel Molina, Maria Sanchez-Ronco, et al.Nature Communications|April 20, 2019
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapyJordi Bertran-Alamillo, Valérie Cattan, Marie Schoumacher, et al.Nature Communications|September 6, 2017
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancerKirstine Jacobsen, Jordi Bertran-Alamillo, Miguel Angel Molina, et al.Journal of Translational Medicine|December 21, 2010
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancerSara Simonetti, Miguel Angel Molina, Cristina Queralt, et al.International Journal of Cancer|January 19, 2020
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept studyClara Mayo-de-Las-Casas, Ana Velasco, Douglas Sanchez, et al.Pageof 3